The results of a survey, in which about 100 insurance experts in the Egyptian market identified prospects, opportunities and challenges in the insurance industry in 2026, show that they predict moderate to strong premium growth for the year.
Insurance companies are facing pressure as major corporate general agencies (GAs) push for new incentives for third-year contract retention.
To achieve the goal of "Insurance for All by 2047", India will need to coordinate action across regulators, insurers, government, technology providers and civil society, according to a new report.
Kuwait's Insurance Regulatory Unit (IRU) directed that insurance and reinsurance companies operating in the country obtain a credit rating from an accredited international agency that meets the prescribed minimum standards.
The acceleration in technological advancement, especially in artificial intelligence and image and sound processing, has led to increasing digital challenges, most notably the phenomenon of deepfakes, according to the Insurers Federation of Egypt (IFE).
Korean insurers are expected to recalibrate their capital strategies to focus on accumulating sustainable core capital in the wake of an announcement by the Financial Services Commission and Financial Supervisory Service about new capital ratio requirements that are to be implemented on 1 January 2027. Otherwise, the insurers may face binding constraints and regulatory intervention.
Korea's Financial Services Commission and Financial Supervisory Service have announced that, starting 1 January 2027, the core capital K-ICS ratio will be mandatory for all insurers under the Korea Insurance Capital Standards (K-ICS).
Twenty-three insurance companies issued a total of 27 capital replenishment bonds and perpetual bonds in 2025, raising an aggregate amount of CNY104.2bn ($14.9bn), according to data from financial information services provider Wind.
Business interruption is the biggest worry for companies in Asia Pacific in 2026, according to the latest edition of the Allianz Risk Barometer. The past year has also been a significant one for accelerated adoption of AI, which is reflected in its ranking as the biggest riser in the annual survey at #2. Changes in legislation and regulation, and market developments are also significant risks, ranking #3 and #4 respectively.
Sustained use of GLP-1 therapies (a class of medications used to manage Type-2 diabetes) can significantly reduce medical cost growth over the long term for employers and improve workforce health outcomes, according to the latest report by Aon.